Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06551402 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 13, 2024 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Along with the current clinical trial, the efficacy and safety of a 150 mg Bid dabigatran administered within 24 hours of randomization after having first-ever cerebral venous thrombosis compared to 20 mg rivaroxaban were assessed through rate of recurrent VTE, mRS, rate of venous recanalization, HIT score, MoCA test, and central and peripheral hemorrhagic complications
Trial Details
NCT Number NCT06551402
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Cerebral Venous Sinus Thrombosis
Related terms Intracranial Thrombosis
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov